$CTGO
Contango ORE, Inc.

2019 Q4 Form 10-Q Financial Statement

#000143774920001903 Filed on February 06, 2020

View on sec.gov

Income Statement

Concept 2019 Q4 2018 Q4
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.151M $1.104M
YoY Change 4.28% 36.27%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $1.151M $1.104M
YoY Change 4.28% 36.27%
Operating Profit
YoY Change
Interest Expense -$1.778M -$782.0K
YoY Change 127.32%
% of Operating Profit
Other Income/Expense, Net -$1.778M
YoY Change
Pretax Income -$2.929M -$1.886M
YoY Change 55.3% 132.81%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$2.929M -$1.886M
YoY Change 55.3% 133.28%
Net Earnings / Revenue
Basic Earnings Per Share -$0.45 -$0.30
Diluted Earnings Per Share -$0.45 -$0.30
COMMON SHARES
Basic Shares Outstanding 6.439M 6.261M
Diluted Shares Outstanding 6.439M 6.261M

Balance Sheet

Concept 2019 Q4 2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.355M $10.43M
YoY Change -48.65% -34.08%
Cash & Equivalents $5.355M $10.43M
Short-Term Investments
Other Short-Term Assets $150.4K $106.7K
YoY Change 41.04% -17.95%
Inventory
Prepaid Expenses $150.4K $106.7K
Receivables
Other Receivables
Total Short-Term Assets $5.505M $10.53M
YoY Change -47.74% -33.94%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $5.505M $10.53M
Total Long-Term Assets $0.00 $0.00
Total Assets $5.505M $10.53M
YoY Change -47.74% -33.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $164.1K $10.32K
YoY Change 1489.76% -21.29%
Accrued Expenses $155.1K $54.66K
YoY Change 183.78% -53.6%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $319.3K $64.99K
YoY Change 391.26% -50.36%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $319.3K $64.99K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $319.3K $64.99K
YoY Change 391.23% -50.01%
SHAREHOLDERS EQUITY
Retained Earnings -$54.44M -$46.07M
YoY Change 18.16% 25.92%
Common Stock $59.62M $56.54M
YoY Change 5.45% 7.89%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.186M $10.47M
YoY Change
Total Liabilities & Shareholders Equity $5.505M $10.53M
YoY Change -47.74% -33.94%

Cashflow Statement

Concept 2019 Q4 2018 Q4
OPERATING ACTIVITIES
Net Income -$2.929M -$1.886M
YoY Change 55.3% 133.28%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$455.5K -$402.6K
YoY Change 13.15% 111.88%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$1.800M -$840.0K
YoY Change 114.29%
Cash From Investing Activities -$1.800M -$840.0K
YoY Change 114.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -455.5K -402.6K
Cash From Investing Activities -1.800M -840.0K
Cash From Financing Activities 0.000
Net Change In Cash -2.256M -1.243M
YoY Change 81.52% -111.42%
FREE CASH FLOW
Cash From Operating Activities -$455.5K -$402.6K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q1 ctgo Contingent Salary And Compensation Retention Agreement
ContingentSalaryAndCompensationRetentionAgreement
1500000
CY2019Q4 ctgo Number Of Directors
NumberOfDirectors
4
CY2019Q4 ctgo Options And Warrants Outstanding
OptionsAndWarrantsOutstanding
0
CY2018Q4 ctgo Options And Warrants Outstanding
OptionsAndWarrantsOutstanding
0
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3245817
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3382573
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
164127
CY2019Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
71410
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
155125
CY2019Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
347879
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
59557406
CY2019Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
57935663
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1623323
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1530967
CY2019Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
882881
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1623323
CY2018Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
785999
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1530967
CY2019Q4 us-gaap Assets
Assets
5505273
CY2019Q2 us-gaap Assets
Assets
8761853
CY2019Q4 us-gaap Assets Current
AssetsCurrent
5505273
CY2019Q2 us-gaap Assets Current
AssetsCurrent
8761853
us-gaap Basis Of Accounting
BasisOfAccounting
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.</div> Basis of Presentation</div></div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: justify; text-indent: 24pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;The accompanying unaudited consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) for interim financial information, pursuant to the rules and regulations of the Securities and Exchange Commission (&#x201c;SEC&#x201d;), including instructions to Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-Q and Article <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8</div> of Regulation S-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">X.</div> Accordingly, they do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> include all the information and footnotes required by GAAP for complete annual consolidated financial statements. In the opinion of management, all adjustments considered necessary for a fair statement of the consolidated financial statements have been included. All such adjustments are of a normal recurring nature. The consolidated financial statements should be read in conjunction with the audited financial statements and notes included in the Company<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&#x2019;s Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-K for the fiscal year ended <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> June&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019.</div> The results of operations for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months&nbsp;ended <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> December 31, 2019&nbsp;</div>are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> necessarily indicative of the results that <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> may </div>be expected for the fiscal year ending <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> June&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2020.</div></div></div></div>
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5354841
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8600658
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13810805
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10428232
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6515113
CY2018Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.30
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.75
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.77
CY2019Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6357113
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6515113
CY2019Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6357113
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
65151
CY2019Q2 us-gaap Common Stock Value
CommonStockValue
63571
CY2019Q4 us-gaap Costs And Expenses
CostsAndExpenses
1150944
CY2018Q4 us-gaap Costs And Expenses
CostsAndExpenses
1103750
us-gaap Costs And Expenses
CostsAndExpenses
2141935
us-gaap Costs And Expenses
CostsAndExpenses
2097183
CY2019Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.45
CY2018Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.30
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.75
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.77
CY2019Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.45
CY2018Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.30
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.75
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.77
CY2019Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.45
CY2017Q4 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2019Q4 us-gaap Equity Method Investments
EquityMethodInvestments
CY2019Q2 us-gaap Equity Method Investments
EquityMethodInvestments
CY2019Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1150944
CY2018Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1103750
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2141935
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2097183
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2700000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2790000
CY2019Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1800000
CY2018Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-840000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
-1885730
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-100037
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-191417
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-10763
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-49007
CY2019Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
22412
CY2018Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
58020
us-gaap Investment Income Interest
InvestmentIncomeInterest
62069
us-gaap Investment Income Interest
InvestmentIncomeInterest
116053
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5505273
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8761853
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
319252
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
419289
CY2019Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0
CY2019Q2 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0
CY2019Q4 us-gaap Long Term Debt
LongTermDebt
0
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2700000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2790000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-545817
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-592573
us-gaap Net Income Loss
NetIncomeLoss
-4779866
us-gaap Net Income Loss
NetIncomeLoss
-4771130
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
-2928532
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
2700000
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
2790000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
150432
CY2019Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
161195
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-54436536
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-49656670
us-gaap Share Based Compensation
ShareBasedCompensation
1623323
us-gaap Share Based Compensation
ShareBasedCompensation
1530967
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
0
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
5186021
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
8342564
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
13710072
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
10469909
CY2018Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6260796
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6398193
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: justify; text-indent: 27pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;">Management Estimates.</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">.</div></div></div></div></div></div></div>
CY2019Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6439273
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6209042
CY2019Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6439273
CY2018Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6260796
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6398193
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6209042
CY2019Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6439273
CY2018Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6260796
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6398193
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6209042

Files In Submission

Name View Source Status
0001437749-20-001903-index-headers.html Edgar Link pending
0001437749-20-001903-index.html Edgar Link pending
0001437749-20-001903.txt Edgar Link pending
0001437749-20-001903-xbrl.zip Edgar Link pending
conta20191231_10q.htm Edgar Link pending
ctgo-20191231.xml Edgar Link completed
ctgo-20191231.xsd Edgar Link pending
ctgo-20191231_cal.xml Edgar Link unprocessable
ctgo-20191231_def.xml Edgar Link unprocessable
ctgo-20191231_lab.xml Edgar Link unprocessable
ctgo-20191231_pre.xml Edgar Link unprocessable
explorationprogrammap.jpg Edgar Link pending
ex_170126.htm Edgar Link pending
ex_170127.htm Edgar Link pending
ex_170128.htm Edgar Link pending
ex_170129.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gradexthicknessmainpeakandno.jpg Edgar Link pending
mapofhonaholes2019program-up.jpg Edgar Link pending
phaseicontinuedmap.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tet18-chiefdannydrill_areasc.jpg Edgar Link pending
tet18-copperhilldrill_areasc.jpg Edgar Link pending